Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743958177> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2743958177 endingPage "158" @default.
- W2743958177 startingPage "151" @default.
- W2743958177 abstract "Lenalidomide, a synthetic immunomodulatory drug, has a wide range of features including anti-angiogenic and anti-proliferative properties. To date, researchers have shown that lenalidomide is capable of ameliorating the immune system factors and antitumor responses. Most researchers have reported that lenalidomide enhances the immune response in certain cancer patients through several pathways including the stimulation of Natural Killer cells; notwithstanding, it is still crucial to investigate the effect of lenalidomide on the activity of NK cell cytotoxicity both in vitro and in vivo.To evaluate the in vitro impact of lenalidomide, of different doses, on NK cytotoxicity activity and an in vivo investigation to find the adjuvant behavior of lenalidomide.NK cytotoxocity was measured with the lactate dehydrogenase (LDH) release assay via K562 cells. Lenalidomide was prepared at 1 mM, 2 mM, 4 mM and 8 mM for in vitro study. In addition, the adjuvant properties of lenalidomide were assessed in ten mice groups using NS3 HCV DNA vaccine model of antigen pcDNA3.1(+)/NS3.The results showed that, comparisons to other doses, 4 mMol of lenalidomide was able to noticeably increase NK cytotoxicity activity. Furthermore, the animal model indicated that lenalidomide stimulated NK cytotoxicity in vivo, augmenting it from 16.67% ± 2.07% for the control group to 38.17% ± 2.87% for the lenalidomide-treated.Treatment by lenalidomide and pcDNA3.1(+)/NS3 improves NK cytotoxicity up to 66.80% suggesting that lenalidomide can be used in parallel with such therapeutic vaccines as cancer vaccine or virus vaccines." @default.
- W2743958177 created "2017-08-17" @default.
- W2743958177 creator A5010824491 @default.
- W2743958177 creator A5022179267 @default.
- W2743958177 creator A5045241392 @default.
- W2743958177 date "2017-06-01" @default.
- W2743958177 modified "2023-10-17" @default.
- W2743958177 title "Low Dose of Lenalidomide Enhances NK Cell Activity: Possible Implication as an Adjuvant." @default.
- W2743958177 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28630385" @default.
- W2743958177 hasPublicationYear "2017" @default.
- W2743958177 type Work @default.
- W2743958177 sameAs 2743958177 @default.
- W2743958177 citedByCount "0" @default.
- W2743958177 crossrefType "journal-article" @default.
- W2743958177 hasAuthorship W2743958177A5010824491 @default.
- W2743958177 hasAuthorship W2743958177A5022179267 @default.
- W2743958177 hasAuthorship W2743958177A5045241392 @default.
- W2743958177 hasConcept C109316439 @default.
- W2743958177 hasConcept C150903083 @default.
- W2743958177 hasConcept C185592680 @default.
- W2743958177 hasConcept C202751555 @default.
- W2743958177 hasConcept C203014093 @default.
- W2743958177 hasConcept C207001950 @default.
- W2743958177 hasConcept C2776063141 @default.
- W2743958177 hasConcept C2776364478 @default.
- W2743958177 hasConcept C2777863537 @default.
- W2743958177 hasConcept C40677261 @default.
- W2743958177 hasConcept C55493867 @default.
- W2743958177 hasConcept C71924100 @default.
- W2743958177 hasConcept C86803240 @default.
- W2743958177 hasConcept C8891405 @default.
- W2743958177 hasConcept C98274493 @default.
- W2743958177 hasConceptScore W2743958177C109316439 @default.
- W2743958177 hasConceptScore W2743958177C150903083 @default.
- W2743958177 hasConceptScore W2743958177C185592680 @default.
- W2743958177 hasConceptScore W2743958177C202751555 @default.
- W2743958177 hasConceptScore W2743958177C203014093 @default.
- W2743958177 hasConceptScore W2743958177C207001950 @default.
- W2743958177 hasConceptScore W2743958177C2776063141 @default.
- W2743958177 hasConceptScore W2743958177C2776364478 @default.
- W2743958177 hasConceptScore W2743958177C2777863537 @default.
- W2743958177 hasConceptScore W2743958177C40677261 @default.
- W2743958177 hasConceptScore W2743958177C55493867 @default.
- W2743958177 hasConceptScore W2743958177C71924100 @default.
- W2743958177 hasConceptScore W2743958177C86803240 @default.
- W2743958177 hasConceptScore W2743958177C8891405 @default.
- W2743958177 hasConceptScore W2743958177C98274493 @default.
- W2743958177 hasIssue "2" @default.
- W2743958177 hasLocation W27439581771 @default.
- W2743958177 hasLocation W27439581772 @default.
- W2743958177 hasOpenAccess W2743958177 @default.
- W2743958177 hasPrimaryLocation W27439581771 @default.
- W2743958177 hasRelatedWork W1577850276 @default.
- W2743958177 hasRelatedWork W1982027601 @default.
- W2743958177 hasRelatedWork W1983855168 @default.
- W2743958177 hasRelatedWork W200909032 @default.
- W2743958177 hasRelatedWork W2014382675 @default.
- W2743958177 hasRelatedWork W2416964709 @default.
- W2743958177 hasRelatedWork W2464301138 @default.
- W2743958177 hasRelatedWork W2517050254 @default.
- W2743958177 hasRelatedWork W2793519975 @default.
- W2743958177 hasRelatedWork W82409999 @default.
- W2743958177 hasVolume "14" @default.
- W2743958177 isParatext "false" @default.
- W2743958177 isRetracted "false" @default.
- W2743958177 magId "2743958177" @default.
- W2743958177 workType "article" @default.